About Us

We’re all about building
a healthier society

We believe that DNA testing can empower healthcare professionals and their patients. We understand the concerns that surround inherited genetic illness, cancer and serious health conditions and work to mitigate the risks and develop more targeted solutions. Our genetic screening and advisory services apply the latest technology and data analysis to assist in doctors and specialists providing effective treatments options.

Our Vision

We aim to be a leading global innovator in the biotechnology industry by continuously developing ground-breaking molecular diagnostic (MDx) technologies, increasing health awareness in society and inspiring future generations in order to achieve a healthier community with higher standard of living.

We are to be concerned with their health by striving ourselves toward “A step ahead for healthcare”.

Our Mission

We are dedicated to providing the public with the best preventive and the most precise disease diagnosis through the diligence of our devoted experts, the guarantee of our high-quality laboratory services, and the continuation of our innovative biotechnological advancement.

Proven Technology

Molecular diagnostics technology moves fast. Newer tests tend to be quicker, more revealing and more expensive. Older tests often cost less but may not be as informative. There is a valuable role for both. Our goal is to give medical professionals and patients the widest possible choice. Our technology includes cutting edge next-generation sequencing (NGS) and other frequently used methods such as RT-PCR and Sanger sequencing.

A Step Ahead With Technology

Personalized treatments are increasingly preferred when facing many diseases and conditions. Such treatments depend on finding and interpreting individual genetic information. However, this information is often complex and can overwhelm conventional data systems.

Pangenia’s advanced test platforms can rapidly process huge amounts of genetic information within a shorter time. Our analytical instruments utilize next-generation sequencing (NGS) technology which can meticulously screen sections of an individual’s genome to identify mutations. This can be hugely effective in designing personalized treatments. We also provide real-time PCR and Sanger sequencing test services to meet patients’ differing needs.

Next-Generation Sequencing (NGS)

NGS technology targets genes and mutations relevant to particular cancers. With significantly higher read length and read depth than traditional techniques, NGS allows us to sequence large genomic regions, providing comprehensive genetic profiles in a single efficient and cost-effective report. This form of testing helps identify rare somatic mutations which may have been misinterpreted as negative.

Real-time PCR

Real-time PCR testing allows us to analyze multiple targets simultaneously within a single reaction. This has a number of advantages, and can provide internal controls, lower reagent costs and preserve precious samples. Real-time PCR testing can provide reports in three to five days.

Our Team

Dr. Sherman Zheng

Dr. Zheng was a medical doctor in China’s Chang Chun Hospital for 10 years. He then worked as a Senior Scientist at UBI in New York before accepting a position at New York University.

Prof. Yuk-Lam Lo

With an outstanding career that spans science, business and innovation, Professor Lo is widely considered the “Father of Biotechnology” in Hong Kong.

Dr. See-Ying Tam

Currently Principal Investigator with the Department of Pathology, Dr. Tam joined Stanford University in 1999. He is also an Honorary Associate Professor at The University of Hong Kong.

Dr. Christopher Corless
Consulting Specialist
Dr. Corless is an expert in applying molecular diagnostics to the classification and prognostication of solid tumors. His work has been published in more than 200 publications. Dr. Corless is currently the Executive Director and Chief Medical Officer at Knight Diagnostics Laboratories in Oregon, USA.

Certifications and Accreditations

Partner lab –
Knight Diagnostic Laboratories

To complement our in-house expertise, we work closely with KDL to bring oncologists a wide selection of tests. US-based KDL is a global leader in developing genetic tests for solid tumors and hematopoietic malignancies.

College of American Pathologists (CAP) accreditation – Pathology & MP

Clinical Laboratory Improvement Act (CLIA) by the Centers of Medicare and Medicaid Services (CMS) – Pathology